142217-77-4,
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol,
Entecavir Intermediate IV,
Cyclopentanol, 5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-,
W-205568,
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cydopentanol,
(1S,2S,3S,5S)-5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-Cyclopentanol,
entecavir-4,
AK-33259,
n-1-ol,
CYC088,
CYC089,
SCHEMBL2519691,
CTK8B4566,
DTXSID90672073,
C32H33N5O4,
BCP21001,
ANW-45489,
CE0038,
RW2435,
AKOS015896664,
ZINC100008388,
AC-5919,
AM84384,
AN-10512,
DS-12112,
TC-134234,
R3-04,
ST24026089,
W3096,
217A774,
A807869,
I06-2208,
(1S,2S,3S,5S)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopenta,
(1s,2s,3s,5s)-5-(2-amino-6-(benzyloxy)-9h-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopenta,
(1S,2S,3S,5S)-5-(2-amino-6-benzyloxy-purin-9-yl)-3-benzyloxy-2-(benzyloxymethyl)cyclopentanol,
(1S,2S,3S,5S)-5-(2-amino-6-phenylmethoxy-9-purinyl)-3-phenylmethoxy-2-(phenylmethoxymethyl)-1-cyclopentanol,
(1S,2S,3S,5S)-5-(2-azanyl-6-phenylmethoxy-purin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol,
(1S,2S,3S,5S)-5-[2-Amino-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-[(benzyloxy)methyl]cyclopentan-1-ol,
Entecavir intermediates D,
SYPCZZWUNIHLBU-COROXYKFSA-N,
ACN-039762,
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benz yloxy)-2-(benzyloxymethyl)cyclopentanol,
(1S,2S,3S,5S)-5-(2-amino-6-phenylmethoxypurin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol,